Avoro Capital Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.18 Billion
- Q1 2025
A detailed history of Avoro Capital Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 12,222,222 shares of APLS stock, worth $245 Million. This represents 4.32% of its overall portfolio holdings.
Number of Shares
12,222,222
Previous 12,222,222
-0.0%
Holding current value
$245 Million
Previous $390 Million
31.46%
% of portfolio
4.32%
Previous 5.68%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
291Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$247 Million0.05% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$238 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$203 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$193 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$116 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.2B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...